Niraparib With beVAcizumab After Complete cytoreductioN in Patients With ovArian Cancer
Clinical trial NCT05183984 · RECRUITING
Trial details
- NCT number
- NCT05183984
- Sponsor
- ARCAGY/ GINECO GROUP
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-01
- Primary completion
- 2027-02-01
- Enrollment
- 390
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.